ClearanceBrief
Recall Z-2975-2026 ยท LBZ Enzyme Immunoassay, Quinidine

Siemens Healthcare Diagnostics, Inc.

Syva EMIT 2000 Quinidine Assay REF: 4Q019UL Contents: 1x28 mL, 1x14mL

DateAug 17, 2026 (initiated Jul 13, 2026)
StatusOpen, Classified
ReasonDue to unacceptable precision performance exhibited in certain lots of the Emit 2000 Quinidine Assay, which may lead to erroneously elevated quinidine measurements, creating risk of sub-optimal patient treatment, including potential life-threatening cardiac arrhythmias or inadequate antimalarial therapy.
Root causeUnknown/Undetermined by firm
ActionOn July 14, 2026, Simens Healthineers issued a Urgent Medical Device Correction notification via FedEx. Simens asked consignees to take the following actions: 1. Review this letter with your Medical Director to determine the appropriate course of action, including for any previously generated results, if applicable. 2. Discontinue use of and discard the kit lots listed in the Products Section. 3. Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days. 4. Retain this letter with your laboratory records and forward this letter to those who ma
Quantity20 units
DistributionWorldwide - US Nationwide distribution in the state of CA and the country of Italy.
FDA recordOpen on fda.gov

510(k) clearances named in this recall

K922913EMIT 2000 QUINDINE ASSAY QUIDIDINE CALIBRATORS
Syva Co., Aug 24, 1992